CDNA
Price
$19.24
Change
-$0.25 (-1.28%)
Updated
Jul 3 closing price
Capitalization
548.33M
38 days until earnings call
SNNUF
Price
$15.36
Change
-$0.23 (-1.48%)
Updated
Jul 1 closing price
Capitalization
13.3B
Interact to see
Advertisement

CDNA vs SNNUF

Header iconCDNA vs SNNUF Comparison
Open Charts CDNA vs SNNUFBanner chart's image
CareDx
Price$19.24
Change-$0.25 (-1.28%)
Volume$309.72K
Capitalization548.33M
Smith & Nephew
Price$15.36
Change-$0.23 (-1.48%)
Volume$5K
Capitalization13.3B
CDNA vs SNNUF Comparison Chart in %
Loading...
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNNUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDNA vs. SNNUF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDNA is a Hold and SNNUF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CDNA: $19.24 vs. SNNUF: $15.35)
Brand notoriety: CDNA and SNNUF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CDNA: 25% vs. SNNUF: 251%
Market capitalization -- CDNA: $548.33M vs. SNNUF: $13.3B
CDNA [@Medical Specialties] is valued at $548.33M. SNNUF’s [@Medical Specialties] market capitalization is $13.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDNA’s FA Score shows that 0 FA rating(s) are green whileSNNUF’s FA Score has 1 green FA rating(s).

  • CDNA’s FA Score: 0 green, 5 red.
  • SNNUF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDNA and SNNUF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDNA’s TA Score shows that 5 TA indicator(s) are bullish while SNNUF’s TA Score has 3 bullish TA indicator(s).

  • CDNA’s TA Score: 5 bullish, 5 bearish.
  • SNNUF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CDNA is a better buy in the short-term than SNNUF.

Price Growth

CDNA (@Medical Specialties) experienced а -0.26% price change this week, while SNNUF (@Medical Specialties) price change was +5.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

CDNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNNUF($13.3B) has a higher market cap than CDNA($548M). SNNUF YTD gains are higher at: 22.108 vs. CDNA (-10.135). SNNUF has higher annual earnings (EBITDA): 874M vs. CDNA (-84.92M). SNNUF has more cash in the bank: 516M vs. CDNA (235M). CDNA has less debt than SNNUF: CDNA (34.2M) vs SNNUF (2.89B). SNNUF has higher revenues than CDNA: SNNUF (5.22B) vs CDNA (280M).
CDNASNNUFCDNA / SNNUF
Capitalization548M13.3B4%
EBITDA-84.92M874M-10%
Gain YTD-10.13522.108-46%
P/E RatioN/A58.48-
Revenue280M5.22B5%
Total Cash235M516M46%
Total Debt34.2M2.89B1%
FUNDAMENTALS RATINGS
CDNA vs SNNUF: Fundamental Ratings
CDNA
SNNUF
OUTLOOK RATING
1..100
8150
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4694
PRICE GROWTH RATING
1..100
5047
P/E GROWTH RATING
1..100
8381
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNNUF's Valuation (6) in the null industry is significantly better than the same rating for CDNA (95) in the Medical Specialties industry. This means that SNNUF’s stock grew significantly faster than CDNA’s over the last 12 months.

SNNUF's Profit vs Risk Rating (100) in the null industry is in the same range as CDNA (100) in the Medical Specialties industry. This means that SNNUF’s stock grew similarly to CDNA’s over the last 12 months.

CDNA's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for SNNUF (94) in the null industry. This means that CDNA’s stock grew somewhat faster than SNNUF’s over the last 12 months.

SNNUF's Price Growth Rating (47) in the null industry is in the same range as CDNA (50) in the Medical Specialties industry. This means that SNNUF’s stock grew similarly to CDNA’s over the last 12 months.

SNNUF's P/E Growth Rating (81) in the null industry is in the same range as CDNA (83) in the Medical Specialties industry. This means that SNNUF’s stock grew similarly to CDNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDNASNNUF
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
59%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
44%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
52%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
47%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNNUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGEN1.530.09
+6.25%
Oragenics
GCMG11.620.12
+1.04%
GCM Grosvenor
NAVI14.820.09
+0.61%
Navient Corp
ATR161.040.72
+0.45%
AptarGroup
APT4.75-0.11
-2.26%
Alpha Pro Tech Ltd

CDNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDNA has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CDNA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDNA
1D Price
Change %
CDNA100%
-1.28%
VCYT - CDNA
45%
Loosely correlated
-0.25%
ILMN - CDNA
44%
Loosely correlated
+0.46%
NTRA - CDNA
43%
Loosely correlated
+0.12%
GKOS - CDNA
40%
Loosely correlated
-0.13%
BLFS - CDNA
39%
Loosely correlated
+0.40%
More

SNNUF and

Correlation & Price change

A.I.dvisor tells us that SNNUF and CDNA have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNNUF and CDNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNNUF
1D Price
Change %
SNNUF100%
N/A
CDNA - SNNUF
23%
Poorly correlated
-1.28%
CSTL - SNNUF
23%
Poorly correlated
+1.45%
SNN - SNNUF
22%
Poorly correlated
-1.05%
BFLY - SNNUF
22%
Poorly correlated
-1.02%
TFX - SNNUF
21%
Poorly correlated
-1.39%
More